An Act To Amend Title 16, Title 18, Title 29, And Title 31 Of The Delaware Code, And Chapter 237, Volume 83 Of The Laws Of Delaware, Relating To Primary Care Services.
SB1 is a broad primary care and health-care cost containment measure that revises Delaware law across commercial insurance, state employee health coverage, and Medicaid-related programs. It directs the state’s health care and insurance oversight bodies to monitor and regulate value-based care models, expand reporting on carrier and provider participation, and establish standardized measures for primary care performance and outcomes. The bill also removes a sunset on prior primary care reforms, making those policies permanent rather than temporary.
The bill requires carriers in the commercial market and state-related plans to increase spending on primary care over time, ultimately reaching at least 11.5% of total medical costs, with a portion of that spending delivered through prospective primary care management payments. It also requires carriers to offer value-based care programs, limits the ability to exclude willing providers from those programs, and authorizes the Department of Insurance to adopt regulations on cost calculations, program design, and financial responsibility for certain covered services. For larger carriers, it tightens rate-filing requirements tied to alternative payment models and, beginning in 2028 for commercial plans and fiscal year 2029 for state employee coverage, caps cost per service at 250% of Medicare reimbursement for comparable services unless the plan participates in an approved global budget model.
The bill’s impact on state law is substantial because it amends multiple titles of the Delaware Code and extends primary care spending and rate-setting requirements into commercial insurance, the State Group Health Insurance Plan, and public assistance-related coverage. It also creates a Primary Care Fund to receive certain administrative penalties and use those funds to support implementation by the Statewide Benefits Office and the Division of Medicaid and Medical Assistance. In effect, the bill shifts Delaware further toward regulated, value-based primary care financing and stronger state oversight of insurer spending and pricing practices.
The general sentiment reflected in the bill text is strongly supportive of expanding primary care investment and making earlier reforms permanent. The findings section emphasizes that prior efforts have increased primary care spending, improved provider participation, and not caused a substantial premium impact for consumers, while also arguing that Delaware still has low primary care access and high overall health-care costs. No committee transcript or vote record was provided, so there is no additional recorded opposition or support beyond the bill’s stated policy rationale.
The main points of contention likely center on the scope and enforceability of the mandates, especially the 11.5% primary care spending target, the 250% of Medicare reimbursement cap, and the regulatory authority given to the Department of Insurance and related agencies. Insurers and some provider entities may be concerned about rate-setting constraints, reporting burdens, and the practical effects of excluding high-cost claims in compliance calculations, while supporters are likely to view those same provisions as necessary to control costs, improve access, and ensure more equitable primary care investment.
SB1 amends Titles 16, 18, 29, and 31 of the Delaware Code and repeals a sunset provision from prior legislation, making the state’s primary care reform framework permanent. It expands the authority of the Health Care Commission, the Primary Care Reform Collaborative, and the Office of Value-Based Health Care Delivery; imposes new reporting, payment-model, and rate-filing requirements on insurers; creates a Primary Care Fund for certain penalties; and applies similar primary care spending and value-based care requirements to commercial plans, state employee coverage, and Medicaid-related coverage.
The bill is presented in a strongly favorable light, with legislative findings emphasizing increased primary care investment, stable premiums, and the need to preserve and expand reforms that have already shown results. The text frames the measure as a continuation and scaling-up of successful value-based care efforts, and there is no recorded committee or floor debate in the provided materials to indicate formal opposition or divided sentiment.
The most likely areas of contention are the mandated spending thresholds, the 250% of Medicare reimbursement cap, and the expanded regulatory and reporting obligations placed on carriers and providers. Insurers may object to limits on pricing and required participation in value-based care programs, while some providers may be concerned about administrative requirements, compliance metrics, and how high-cost claims are excluded from calculations. Supporters appear to prioritize affordability, primary care access, and accountability in insurer spending.